Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study

Rachana Shah(University of Pennsylvania), Mahboob Rahman(FIND), C. McLaughlin(University of Leicester), Harold I. Feldman(University of Pennsylvania), Andrea S. Foulkes(Harvard University), Dominic S. Raj(George Washington University), Dawei Xie(Capital Medical University), Muredach P. Reilly(Columbia University Irving Medical Center), Alan S. Go(Kaiser Permanente), M Wolman(University of Pennsylvania), Nehal N. Mehta(National Heart Lung and Blood Institute), Michael J. Fischer(Edward Hines, Jr. VA Hospital), Gregory J. Matthews(University of Massachusetts Amherst), Raymond R. Townsend(University of Pennsylvania), Lawrence J. Appel(Johns Hopkins University), James P. Lash(University of Illinois Chicago), Daniel J. Rader(University of Pennsylvania), Matthew J. Budoff(Foundation for Biomedical Research), Stephen R. Master(Hospital of the University of Pennsylvania), Boyang Chai(California University of Pennsylvania), Jing Chen(Tulane University), Jiang He(Southwestern Medical Center), Akinlolu Ojo(University of Kansas Medical Center), John W. Kusek(National Institute of Diabetes and Digestive and Kidney Diseases)
American Journal of Kidney Diseases
March 22, 2015
Cited by 55


Related Papers